Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Brain Tumor

“Unlocking a New Immune Boost for Cancer Immunotherapy”

Researchers have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating lymphocyte, or TIL therapy.

Avatar photo

Published

on

Unlocking a New Immune Boost for Cancer Immunotherapy

Researchers at Moffitt Cancer Center have made a groundbreaking discovery that could revolutionize cancer immunotherapy. By tapping into the body’s own immune system, they’ve found a way to boost the effectiveness of tumor-infiltrating lymphocyte (TIL) therapy – a treatment already approved by the FDA for melanoma.

The breakthrough involves activating a type of immune cell called B cells and using a natural immune protein called CD40L. This simple tweak in the lab can make TIL therapy work even better for more patients. In fact, results from their study showed that when CD40L was used, TIL cultures grew successfully in 67% of samples, compared to just 33% without it.

The approach not only improved the number and quality of cancer-fighting T cells but also shaved up to one week off the manufacturing time – potentially getting the cellular immunotherapy to patients sooner. Furthermore, the enhanced cells were more “stem-like,” a trait linked to longer-lasting cancer fighting capabilities.

“TIL therapy is one of the most promising treatments we have for solid tumors,” said Daniel Abate-Daga, Ph.D., scientific director of the Cell Therapies Core at Moffitt and lead author of the study. “This discovery could help more patients benefit and do so more quickly.”

The researchers are now leading a clinical trial to test this approach in patients with non-small cell lung cancer, with the hope that CD40L-enhanced TILs will become a next-generation standard in TIL therapy.

Their study was funded by several organizations, including the National Cancer Institution, the SuzyQ Melanoma Fund, and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation.

With this breakthrough, cancer patients may soon have access to more effective treatments that can improve their chances of recovery. The future looks bright for immunotherapy – and it’s all thanks to the tireless efforts of researchers like those at Moffitt Cancer Center.

Brain Tumor

AI Tool Tracks Lung Tumors as You Breathe, Potentially Saving Lives

An AI system called iSeg is reshaping radiation oncology by automatically outlining lung tumors in 3D as they shift with each breath. Trained on scans from nine hospitals, the tool matched expert clinicians, flagged cancer zones some missed, and could speed up treatment planning while reducing deadly oversights.

Avatar photo

Published

on

The article describes how a team of Northwestern Medicine scientists has developed an innovative AI tool called iSeg that can accurately outline lung tumors on CT scans, even as they move with each breath. This is a critical factor in planning radiation treatment, which half of all cancer patients in the US receive during their illness. The study found that iSeg consistently matches expert outlines across hospitals and scan types, and also flags additional areas that some doctors may miss – areas linked to worse outcomes if left untreated.

The AI tool was trained using CT scans and doctor-drawn tumor outlines from hundreds of lung cancer patients treated at nine clinics within the Northwestern Medicine and Cleveland Clinic health systems. The study’s authors believe that iSeg can help reduce delays, ensure fairness across hospitals, and potentially identify areas that doctors might miss – ultimately improving patient care and clinical outcomes.

The research team is now testing iSeg in clinical settings, comparing its performance to physicians in real time. They are also integrating features like user feedback and working to expand the technology to other tumor types, such as liver, brain, and prostate cancers. The team envisions this as a foundational tool that could standardize and enhance how tumors are targeted in radiation oncology.

The study was published today (June 30) in the journal npj Precision Oncology.

Continue Reading

Brain Injury

The Hidden Glitch Behind Hunger: Scientists Uncover the Brain Cells Responsible for Meal Memories

A team of scientists has identified specialized neurons in the brain that store “meal memories” detailed recollections of when and what we eat. These engrams, found in the ventral hippocampus, help regulate eating behavior by communicating with hunger-related areas of the brain. When these memory traces are impaired due to distraction, brain injury, or memory disorders individuals are more likely to overeat because they can’t recall recent meals. The research not only uncovers a critical neural mechanism but also suggests new strategies for treating obesity by enhancing memory around food consumption.

Avatar photo

Published

on

The Hidden Glitch Behind Hunger: Scientists Uncover the Brain Cells Responsible for Meal Memories

Imagine forgetting about lunch and suddenly feeling extremely hungry. It’s a common phenomenon that can lead to overeating and disordered eating behaviors. Researchers have now identified a specific group of brain cells called “meal memory” neurons in laboratory rats that could explain why people with memory problems often overeat.

These specialized cells, found in the ventral hippocampus region of the brain, become active during eating and form what scientists call “meal engrams” – sophisticated biological databases that store information about food consumption experiences. An engram is essentially the physical trace a memory leaves behind in the brain, making it possible for us to recall specific details about our meals.

The discovery has significant implications for understanding human eating disorders. Patients with memory impairments, such as those with dementia or brain injuries that affect memory formation, may often consume multiple meals in quick succession because they cannot remember eating. Furthermore, distracted eating – such as mindlessly snacking while watching television or scrolling on a phone – may impair meal memories and contribute to overconsumption.

Researchers used advanced neuroscience techniques to observe the brain activity of laboratory rats as they ate, providing the first real-time view of how meal memories form. They found that meal memory neurons are distinct from other types of brain cells involved in memory formation. When these neurons were selectively destroyed, lab rats showed impaired memory for food locations but retained normal spatial memory for non-food-related tasks.

The study revealed that meal memory neurons communicate with the lateral hypothalamus, a brain region long known to control hunger and eating behavior. When this hippocampus-hypothalamus connection was blocked, the lab rats overate and could not remember where meals were consumed.

The findings have immediate relevance for understanding human eating disorders and could eventually inform new clinical approaches for treating obesity and weight management. Current weight management strategies often focus on restricting food intake or increasing exercise, but the new research suggests that enhancing meal memory formation could be equally important.

“We’re finally beginning to understand that remembering what and when you ate is just as crucial for healthy eating as the food choices themselves,” said Scott Kanoski, professor of biological sciences at the USC Dornsife College of Letters, Arts and Sciences and corresponding author of the study.

In addition to understanding human eating disorders, this research could also inform new strategies for treating obesity and weight management. Current approaches often focus on restricting food intake or increasing exercise, but the new findings suggest that enhancing meal memory formation could be equally important.

By uncovering the brain cells responsible for meal memories, scientists have taken a significant step towards understanding the complex relationships between our brains, bodies, and eating habits. The discovery of these specialized neurons offers new hope for developing effective treatments and interventions to help individuals manage their weight and improve their overall health.

Continue Reading

Brain Tumor

Uncovering Nature’s Secret: Ginger Compound Shows Promise in Targeting Cancer Cells’ Metabolism

Scientists in Japan have discovered that a natural compound found in a type of ginger called kencur can throw cancer cells into disarray by disrupting how they generate energy. While healthy cells use oxygen to make energy efficiently, cancer cells often rely on a backup method. This ginger-derived molecule doesn t attack that method directly it shuts down the cells’ fat-making machinery instead, which surprisingly causes the cells to ramp up their backup system even more. The finding opens new doors in the fight against cancer, showing how natural substances might help target cancer s hidden energy tricks.

Avatar photo

Published

on

The quest for a cure to cancer has led scientists to explore the depths of nature, seeking answers that can unlock the secrets of this complex disease. One such natural compound is found in kencur ginger, which has shown promise in targeting the metabolic pathway of cancer cells.

In normal human cells, energy is produced through the oxidation of glucose, resulting in the production of ATP (adenosine triphosphate), the primary energy source necessary for life. However, cancer cells take a different approach, using glycolysis to produce ATP even when oxygen is present. This inefficient method, known as the Warburg effect, has puzzled scientists, leading them to wonder why cancer cells choose this pathway.

Associate Professor Akiko Kojima-Yuasa and her team at Osaka Metropolitan University’s Graduate School of Human Life and Ecology have been investigating the cinnamic acid ester ethyl p-methoxycinnamate, a main component of kencur ginger. Their previous research revealed that this compound has inhibitory effects on cancer cells. The team decided to further their study by administering the acid ester to Ehrlich ascites tumor cells, which resulted in some unexpected findings.

The researchers discovered that ethyl p-methoxycinnamate not only disrupts de novo fatty acid synthesis and lipid metabolism but also triggers increased glycolysis as a possible survival mechanism in the cells. This adaptability was theorized to be attributed to the compound’s inability to induce cell death.

“These findings not only provide new insights that supplement and expand the theory of the Warburg effect, which can be considered the starting point of cancer metabolism research, but are also expected to lead to the discovery of new therapeutic targets and the development of new treatment methods,” stated Professor Kojima-Yuasa.

The study’s results have significant implications for cancer research, opening up new avenues for investigation into the metabolic pathways of cancer cells. As scientists continue to explore the mysteries of nature, they may uncover even more secrets that can lead to a deeper understanding and potential cures for this complex disease.

Continue Reading

Trending